TipRanks
Advertisement
Advertisement

FR:DBV Stock Latest News

DBV Technologies: Viaskin Peanut’s Strong Pediatric Prospects and Unchanged $45 Price Target Support Buy Rating
RatingsDBV Technologies: Viaskin Peanut’s Strong Pediatric Prospects and Unchanged $45 Price Target Support Buy Rating
8d ago
DBVT
DBV Technologies Files BLA with FDA for VIASKIN Peanut Patch in Children
PremiumCompany Announcements
DBV Technologies Files BLA with FDA for VIASKIN Peanut Patch in Children
9d ago
DBV Technologies submits BLA to FDA for Viaskin Peanut Patch
PremiumThe Fly
DBV Technologies submits BLA to FDA for Viaskin Peanut Patch
9d ago
DBVT
DBV Technologies Steps Up Investor Outreach Ahead of Key Food Allergy Trial Milestones
PremiumCompany Announcements
DBV Technologies Steps Up Investor Outreach Ahead of Key Food Allergy Trial Milestones
1M ago
DBV Technologies Updates Share Capital and Voting Rights as of August 31, 2026
PremiumCompany Announcements
DBV Technologies Updates Share Capital and Voting Rights as of August 31, 2026
1M ago
DBV Technologies Raises $50 Million via Nasdaq ATM Share Sale
PremiumCompany AnnouncementsDBV Technologies Raises $50 Million via Nasdaq ATM Share Sale
2M ago
DBV Technologies announces sale of $50M of ADSs through ATM program
Premium
The Fly
DBV Technologies announces sale of $50M of ADSs through ATM program
2M ago
DBVT
Fourteen new option listings and one option delisting on July 22nd
Premium
The Fly
Fourteen new option listings and one option delisting on July 22nd
3M ago
ACOG
ARTV
DBV Technologies announces $150M at-the-market offering
PremiumThe Fly
DBV Technologies announces $150M at-the-market offering
3M ago
DBVT
DBV Technologies reports Q2 EPS (12c), consensus (9c)
PremiumThe Fly
DBV Technologies reports Q2 EPS (12c), consensus (9c)
3M ago
DBVT
DBV Technologies: Buy Rating Reaffirmed with Unchanged $46 Price Target as VIASKIN Peanut BLA Timeline and Regulatory Path De‑Risk
PremiumRatings
DBV Technologies: Buy Rating Reaffirmed with Unchanged $46 Price Target as VIASKIN Peanut BLA Timeline and Regulatory Path De‑Risk
3M ago
DBVT
DBV Technologies pushout adds ‘timing risk, not data risk,’ says H.C. Wainwright
PremiumThe Fly
DBV Technologies pushout adds ‘timing risk, not data risk,’ says H.C. Wainwright
3M ago
DBVT
Fein Reiterates Buy on DBV Technologies, Citing Operational BLA Delay and Unchanged $40 Price Target
PremiumRatingsFein Reiterates Buy on DBV Technologies, Citing Operational BLA Delay and Unchanged $40 Price Target
3M ago
DBVT
Cantor stays bullish on DBV despite one month filing delay
Premium
The Fly
Cantor stays bullish on DBV despite one month filing delay
3M ago
DBVT
DBV Technologies delays Viaskin BLA submission to Q3, says Citizens
Premium
The Fly
DBV Technologies delays Viaskin BLA submission to Q3, says Citizens
3M ago
DBVT
DBV Technologies provides Viaskin Peanut Patch BLA submission update
PremiumThe Fly
DBV Technologies provides Viaskin Peanut Patch BLA submission update
3M ago
DBVT
PremiumPre-Earnings
Dbv Technologies SA (UK) (0QAJ) Q1 Earnings Cheat Sheet
5M ago
DBV Technologies Maintained at Buy as Commercialization Prospects Grow; $40 Price Target Reaffirmed
PremiumRatings
DBV Technologies Maintained at Buy as Commercialization Prospects Grow; $40 Price Target Reaffirmed
5M ago
DBVT
DBV Technologies price target raised to $55 from $47 at Citizens
PremiumThe Fly
DBV Technologies price target raised to $55 from $47 at Citizens
5M ago
DBVT
DBV Technologies reports Q1 EPS (11c), consensus (12c)
PremiumThe FlyDBV Technologies reports Q1 EPS (11c), consensus (12c)
5M ago
DBVT
DBV Technologies: Differentiated Viaskin Peanut Profile and Solid Cash Runway Support Buy Rating
Premium
Ratings
DBV Technologies: Differentiated Viaskin Peanut Profile and Solid Cash Runway Support Buy Rating
6M ago
DBVT
DBV Technologies price target lowered to EUR 1.01 from EUR 1.37 at Goldman Sachs
Premium
The Fly
DBV Technologies price target lowered to EUR 1.01 from EUR 1.37 at Goldman Sachs
6M ago
DBVT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >